Biguanides and targeted anti-cancer treatments

por Hanly, Elyse K., Darzynkiewicz, Zbigniew, Tiwari, Raj K.
Publicado 2015

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells

por Hanly, Elyse K., Tuli, Neha Y., Bednarczyk, Robert B., Suriano, Robert, Geliebter, Jan, Moscatello, Augustine L., Darzynkiewicz, Zbigniew, Tiwari, Raj K.
Publicado 2015

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer

por Bednarczyk, Robert B., Tuli, Neha Y., Hanly, Elyse K., Rahoma, Ghada Ben, Maniyar, Rachana, Mittelman, Abraham, Geliebter, Jan, Tiwari, Raj K.
Publicado 2018

PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells

por George, Andrea L., Suriano, Robert, Rajoria, Shilpi, Osso, Maria C., Tuli, Neha, Hanly, Elyse, Geliebter, Jan, Arnold, Angelo N., Wallack, Marc, Tiwari, Raj K.
Publicado 2015

mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib

por Hanly, Elyse K., Bednarczyk, Robert B., Tuli, Neha Y., Moscatello, Augustine L., Halicka, H. Dorota, Li, Jiangwei, Geliebter, Jan, Darzynkiewicz, Zbigniew, Tiwari, Raj K.
Publicado 2015

Disruption of mutated BRAF signaling modulates thyroid cancer phenotype

por Hanly, Elyse K, Rajoria, Shilpi, Darzynkiewicz, Zbigniew, Zhao, Hong, Suriano, Robert, Tuli, Neha, George, Andrea L, Bednarczyk, Robert, Shin, Edward J, Geliebter, Jan, Tiwari, Raj K
Publicado 2014

Development and Validation of Machine Learning Models for Predicting Occult Nodal Metastasis in Early-Stage Oral Cavity Squamous Cell Carcinoma

por Farrokhian, Nathan, Holcomb, Andrew J., Dimon, Erin, Karadaghy, Omar, Ward, Christina, Whiteford, Erin, Tolan, Claire, Hanly, Elyse K., Buchakjian, Marisa R., Harding, Brette, Dooley, Laura, Shinn, Justin, Wood, C. Burton, Rohde, Sarah L., Khaja, Sobia, Parikh, Anuraag, Bulbul, Mustafa G., Penn, Joseph, Goodwin, Sara, Bur, Andrés M.
Publicado 2022